AU2564497A - Use of formes f hyaluronic acid (ha) for the treatment of cancer - Google Patents
Use of formes f hyaluronic acid (ha) for the treatment of cancerInfo
- Publication number
- AU2564497A AU2564497A AU25644/97A AU2564497A AU2564497A AU 2564497 A AU2564497 A AU 2564497A AU 25644/97 A AU25644/97 A AU 25644/97A AU 2564497 A AU2564497 A AU 2564497A AU 2564497 A AU2564497 A AU 2564497A
- Authority
- AU
- Australia
- Prior art keywords
- formes
- cancer
- treatment
- hyaluronic acid
- hyaluronic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002175282A CA2175282A1 (fr) | 1996-04-29 | 1996-04-29 | Utilisation de diverses formes d'acide hyaluronique (ah) pour le traitement du cancer |
| CA2175282 | 1996-04-29 | ||
| PCT/CA1997/000283 WO1997040841A1 (fr) | 1996-04-29 | 1997-04-28 | Emploi de formes d'acide hyaluronique (ha) pour therapie anticancereuse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2564497A true AU2564497A (en) | 1997-11-19 |
Family
ID=4158095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU25644/97A Abandoned AU2564497A (en) | 1996-04-29 | 1997-04-28 | Use of formes f hyaluronic acid (ha) for the treatment of cancer |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR006892A1 (fr) |
| AU (1) | AU2564497A (fr) |
| CA (1) | CA2175282A1 (fr) |
| WO (1) | WO1997040841A1 (fr) |
| ZA (1) | ZA973622B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888984A (en) * | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| DK1140198T3 (da) | 1999-01-13 | 2008-03-10 | Alchemia Oncology Pty Ltd | Anvendelse af hyaluronan til fremstilling af et lægemiddel til forögelse af cytotoksiske lægemidlers virkningsgrad |
| US8003782B1 (en) | 1999-02-01 | 2011-08-23 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| CA2365767A1 (fr) * | 1999-03-15 | 2000-09-21 | Trustees Of Boston University | Inhibition d'une angiogenese |
| US9066919B2 (en) | 2000-07-14 | 2015-06-30 | Alchemia Oncology Pty Limited | Hyaluronan as a chemo-sensitizer in the treatment of cancer |
| AUPQ879500A0 (en) | 2000-07-14 | 2000-08-10 | Meditech Research Limited | Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease |
| AU760404B2 (en) * | 2000-07-14 | 2003-05-15 | Alchemia Oncology Pty Limited | Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease |
| AU2001281368B2 (en) * | 2000-07-31 | 2005-07-28 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
| US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
| AU2002325635C1 (en) * | 2001-08-27 | 2008-09-25 | Alchemia Oncology Pty Limited | Improved therapeutic protocols |
| WO2003018062A1 (fr) * | 2001-08-27 | 2003-03-06 | Meditech Research Limited | Protocoles therapeutiques ameliores |
| ITPD20020271A1 (it) | 2002-10-18 | 2004-04-19 | Fidia Farmaceutici | Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati. |
| JP5465431B2 (ja) | 2005-07-27 | 2014-04-09 | アルケミア オンコロジー ピーティーワイ リミテッド | ヒアルロナンを用いる治療プロトコル |
| EP1922077A4 (fr) | 2005-09-07 | 2013-03-06 | Alchemia Oncology Pty Ltd | Compositions thérapeutiques comprenant de l hyaluronane et des anticorps therapeutiques, et procédes thérapeutiques |
| US9375447B2 (en) * | 2013-03-14 | 2016-06-28 | National Cheng Kung University | Modified hyaluronan and uses thereof in cancer treatment |
| CN105311051A (zh) | 2014-05-26 | 2016-02-10 | 陈松源 | 具有增加抗肿瘤药物疗效的载体溶媒、制备方法及其给药途径 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6117A (ja) * | 1984-06-11 | 1986-01-06 | Seikagaku Kogyo Co Ltd | ムコ多糖系癌転移抑制剤 |
| US5262403A (en) * | 1986-03-10 | 1993-11-16 | Board Of Regents, The University Of Texas System | Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness of metastatic profusion-II |
| CA2067211C (fr) * | 1990-07-24 | 2004-06-15 | Katsukiyo Sakurai | Glycosaminoglycan lie aux lipides ou aux phospholipides, procede de production et inhibiteur de metastase |
| CA2122519C (fr) * | 1994-04-29 | 2001-02-20 | Rudolf Edgar Dr. Falk | Traitement du cancer et prevention des metastases |
| WO1994020115A2 (fr) * | 1993-03-10 | 1994-09-15 | Miles, Inc. | Acide hyaluronique utilise comme traitement contre le cancer |
-
1996
- 1996-04-29 CA CA002175282A patent/CA2175282A1/fr not_active Abandoned
-
1997
- 1997-04-25 ZA ZA9703622A patent/ZA973622B/xx unknown
- 1997-04-28 AU AU25644/97A patent/AU2564497A/en not_active Abandoned
- 1997-04-28 WO PCT/CA1997/000283 patent/WO1997040841A1/fr active Application Filing
- 1997-04-29 AR ARP970101754A patent/AR006892A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997040841A1 (fr) | 1997-11-06 |
| ZA973622B (en) | 1997-11-25 |
| CA2175282A1 (fr) | 1997-10-30 |
| AR006892A1 (es) | 1999-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3673499A (en) | Hydrogel for the therapeutic treatment of aneurysms | |
| AU2228297A (en) | Use of isoniazid for the treatment of hyperlipoproteinemia | |
| AU1958897A (en) | Egf-genistein conjugates for the treatment of cancer | |
| AU2557397A (en) | Removal of tissue | |
| AU3548795A (en) | Benzopyranopyrazolyl derivatives for the treatment of inflammation | |
| EP0815838A3 (fr) | Préparation par les soins de la peau à l'application externe | |
| AU3441197A (en) | 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes | |
| AU698509B2 (en) | Compositions for the treatment of rheumatoid-based arthritic diseases | |
| AU3378297A (en) | Blood treatment system | |
| AU2564497A (en) | Use of formes f hyaluronic acid (ha) for the treatment of cancer | |
| AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| AUPM761094A0 (en) | Treatment of hides | |
| AU2508597A (en) | Drug for the treatment of tumours | |
| AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
| AU4774597A (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin infections | |
| AU2387097A (en) | Substituted benzylamines and their use for the treatment of depression | |
| AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
| AU3187595A (en) | Compounds for the treatment of restenosis | |
| AU3596797A (en) | Methods for the treatment of apolipoprotein e related diseases | |
| AU1878201A (en) | Composition for the treatment of damaged tissue | |
| AU3814599A (en) | Use of erythropoietin for the treatment of haemochromatoses | |
| AU5339398A (en) | Apparatus for cardiac treatment | |
| AU2068295A (en) | Skin treatment composition | |
| AU1112099A (en) | Tissue removal | |
| AU5699396A (en) | Compositions for the treatment of skin conditions |